In Acute Myocardial Infarction Liver Parameters Are Associated With Stenosis Diameter

Theodor Baars1, Ursula Neumann, Mona Jinawy

  • 1From the Department for Cardiology, West German Heart and Vascular Centre Essen, University Hospital, University Duisburg-Essen, Essen, Germany (TB, MJ, SH, RE); Department of Bioinformatics, Straubing Center of Science, University of Applied Science Weihenstephan-Triesdorf, Straubing, Germany (UN, MR, DH); and Department of Gastroenterology and Hepatology, University Hospital, University Duisburg-Essen (J-PS, JK, GG, AC), Essen, Germany.

Medicine
|February 13, 2016
PubMed

Insights

Noninvasive liver enzymes and routine blood markers can predict coronary artery stenosis severity in acute myocardial infarction (AMI) patients. This may reduce the need for invasive cardiac catheterization in low-risk individuals.

Area of Science:

  • Cardiology
  • Biochemistry
  • Medical Diagnostics

Background:

  • Acute myocardial infarction (AMI) necessitates accurate risk stratification to guide treatment.
  • Intracardiac catheterization, while definitive, carries risks and complications.
  • Liver enzymes are implicated in cardiovascular disease risk, suggesting a potential role in AMI assessment.

Purpose of the Study:

  • To analyze the predictive value of liver serum markers for coronary artery stenosis severity in AMI patients.
  • To identify noninvasive parameters that can assess stenosis severity, potentially avoiding invasive procedures.

Main Methods:

  • Retrospective evaluation of 437 AMI patients undergoing percutaneous coronary intervention (PCI).
  • Quantitative coronary angiography to determine minimal lumen diameter (MLD) and percent stenosis diameter (SD).
  • Random forests (RF) analysis to associate routine heart and liver parameters with SD, developing a prediction model (M10).

Main Results:

  • Significant differences in age, alkaline phosphatase (AP), aspartate aminotransferase (AST), and MLD were observed between stenosis severity groups (SD ≥ 50% vs. < 50%).
  • Age, AST, alanine aminotransferase (ALT), and troponin correlated significantly with SD; MLD showed an inverse correlation.
  • The M10 model (including age, BMI, AP, AST, ALT, gamma-glutamyltransferase, creatinine, troponin) achieved an AUC of 69.7% for predicting stenosis severity.

Conclusions:

  • Routine liver parameters are significantly associated with coronary artery stenosis severity in AMI.
  • A noninvasive model using readily available parameters can identify stenosis severity in AMI.
  • This approach may help avoid unnecessary coronary angiography in lower-risk AMI patients.

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
414
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.5K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
695
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
948
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552